---
$id: https://graph.org.ai/products/commodity/51384619
$type: Product
source: UNSPSC
code: "51384619"
title: "Trifezolac"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trifezolac

**UNSPSC Code**: 51384619
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XJ3W180C22. European Medicines Agency schedules Trifezolac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11283MIG. Trifezolac generally arises in the molecular formula C23H18N2O2. The term TRIFEZOLAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) TRIFEZOLAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trifezolac under HS 29331990 and SITC 51571. As of Q4 2014, TRIFEZOLAC remains the US FDA Preferred Term for this commodity. Trifezolac bears US NLM identifiers UMLS ID C2700077 and NCI Concept Code C76824. SMILES: OC(=O)CC1C(N(NC1C1CCCCC1)C1CCCCC1)C1CCCCC1.

